Aardvark Therapeutics, Inc. Common Stock (AARD) Financials

AARD Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 98.6 million 11.6 million
Dec. 31, 2025 117.2 million 10.5 million
Sept. 30, 2025 133.2 million 10.9 million
June 30, 2025 147.5 million 10.6 million

AARD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -18.9 million 2.0 million
Dec. 31, 2025 -14.4 million 1.6 million
Sept. 30, 2025 -18.5 million 1.5 million
June 30, 2025 -9.9 million 634000

AARD Net Income

No data available :(

AARD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 91.2 million - 336000
Dec. 31, 2025 110.0 million - 441000
Sept. 30, 2025 126.4 million - 545000
June 30, 2025 141.8 million - 645000

AARD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 21.8 million
Dec. 31, 2025 21.8 million
Sept. 30, 2025 21.7 million
June 30, 2025 21.7 million

AARD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 16.6 million 5.9 million -
Dec. 31, 2025 - 14.3 million 4.4 million -
Sept. 30, 2025 4000 13.7 million 4.0 million -
June 30, 2025 91000 13.1 million 2.7 million -

AARD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 11000
Dec. 31, 2025 - 10000
Sept. 30, 2025 - 10000
June 30, 2025 - -

AARD

Price: $3.93

52 week price:
3.35
17.94

Earnings Per Share: -3.21 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 80.3 million

Links: